POLYMED
Poly Medicure Limited (POLYMED) Stock Analysis
Poly Medicure Limited manufactures medical devices including infusion sets, catheters, and dialysis products for India and exports. It supplies hospitals and OEM partners with disposable medical products. The company competes in regulated medical device markets. It is listed on Indian stock exchanges.
Healthcare › Medical Instruments & Supplies
₹1,705.30
-1.91% 1W | -11.80% 52W
Market Cap
17.3k CR
P/E Ratio
54.9
52W High
₹2094.3
52W Low
₹1182
Div. Yield
0.2%
Beta
0
50 DMA
₹1725.3
200 DMA
₹1561.8
Profit Margin
15.8%
Inst. Own.
18.2%
✅ BOUNCE FROM SUPPORT
✅ BOUNCE FROM SUPPORT
Fundamentals
Profit & Loss
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 321 | 337 | 340 | 378 | 385 | 420 | 424 | 441 | 403 | 444 | 494 | 535 | 525 |
| Expenses | 234 | 253 | 249 | 282 | 281 | 305 | 310 | 321 | 298 | 329 | 382 | 424 | 400 |
| Operating Profit | 87 | 84 | 90 | 96 | 104 | 115 | 114 | 119 | 106 | 115 | 111 | 110 | 125 |
| OPM % | 27% | 25% | 27% | 26% | 27% | 27% | 27% | 27% | 26% | 26% | 23% | 21% | 24% |
| Other Income | 14 | 15 | 17 | 15 | 17 | 27 | 24 | 27 | 43 | 35 | 21 | 19 | 35 |
| Interest | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 3 | 6 | 6 | 6 |
| Depreciation | 16 | 16 | 16 | 16 | 20 | 21 | 21 | 21 | 23 | 25 | 29 | 38 | 36 |
| Profit before tax | 83 | 81 | 88 | 92 | 98 | 118 | 113 | 123 | 123 | 122 | 98 | 85 | 117 |
| Tax % | 24% | 23% | 26% | 26% | 25% | 26% | 25% | 25% | 24% | 25% | 27% | 24% | 27% |
| Net Profit | 63 | 62 | 65 | 68 | 74 | 87 | 85 | 92 | 93 | 92 | 71 | 65 | 85 |
| EPS in Rs | 6.54 | 6.48 | 6.78 | 7.12 | 7.71 | 8.63 | 8.41 | 9.06 | 9.19 | 9.06 | 7.00 | 6.54 | 8.49 |
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 390 | 411 | 454 | 519 | 610 | 687 | 785 | 922 | 1,115 | 1,375 | 1,669 | 1,875 | 1,997 |
| Expenses | 304 | 323 | 361 | 397 | 479 | 520 | 569 | 707 | 847 | 1,014 | 1,213 | 1,429 | 1,536 |
| Operating Profit | 86 | 88 | 93 | 122 | 131 | 166 | 216 | 215 | 267 | 361 | 456 | 446 | 461 |
| OPM % | 22% | 21% | 21% | 23% | 22% | 24% | 28% | 23% | 24% | 26% | 27% | 24% | 23% |
| Other Income | 28 | 8 | 14 | 16 | 20 | 21 | 22 | 40 | 38 | 60 | 94 | 119 | 110 |
| Interest | 10 | 10 | 8 | 12 | 14 | 20 | 11 | 6 | 11 | 14 | 14 | 21 | 22 |
| Depreciation | 19 | 21 | 24 | 29 | 37 | 41 | 48 | 54 | 57 | 63 | 83 | 116 | 128 |
| Profit before tax | 85 | 65 | 75 | 97 | 100 | 126 | 180 | 195 | 237 | 344 | 453 | 427 | 422 |
| Tax % | 27% | 27% | 27% | 27% | 35% | 24% | 25% | 25% | 25% | 25% | 25% | 25% | |
| Net Profit | 62 | 48 | 55 | 71 | 65 | 96 | 136 | 147 | 179 | 258 | 339 | 321 | 313 |
| EPS in Rs | 7.07 | 5.47 | 6.25 | 8.00 | 7.41 | 10.86 | 14.17 | 15.28 | 18.69 | 26.91 | 33.41 | 31.78 | 31.09 |
| Dividend Payout % | 18% | 27% | 40% | 25% | 27% | 18% | 18% | 16% | 16% | 11% | 10% | 11% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | 19.0% | 19.0% | 16.0% |
| Profit CAGR | 15.0% | 14.0% | 19.0% |
Shareholding Pattern
Promoters62.44%
FIIs11.41%
DIIs11.72%
Public14.43%
Promoters62.42%
FIIs9.77%
DIIs13.53%
Public14.28%
Promoters62.42%
FIIs9.41%
DIIs13.84%
Public14.34%
Promoters62.42%
FIIs5.92%
DIIs15.60%
Public16.08%
Promoters62.42%
FIIs5.56%
DIIs16.08%
Public15.94%
Promoters53.32%
FIIs16.21%
DIIs3.67%
Public26.79%
Promoters53.14%
FIIs12.37%
DIIs7.21%
Public27.25%
Promoters62.44%
FIIs11.46%
DIIs11.96%
Public14.13%
Promoters62.42%
FIIs5.92%
DIIs15.60%
Public16.08%
Promoters62.42%
FIIs5.56%
DIIs16.08%
Public15.94%
POLYMED
Holdings Analysis
Key strengths & risk signals
75
Overall
78
Fundamental
73
Technical
Risks (4)
NEGLIGIBLE DIVIDEND! 0.2% yield - little to no income.
RECOVERY MODE! Current price (1705.3) above 200-day but below 50-day.
WEAK YEAR! Stock declined 11.8% in the last year.
WEAK MOMENTUM! Limited price growth - -1.9% (1 week), -1.6% (1 month), 3.4% (3 months).
Strengths (4)
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
BULLISH TREND! 50-day average (1725.3) is above 200-day average (1561.8) - positive signal.
BULLISH SENTIMENT! In last 30 days: 12 up days, 17 down days. Avg volume on up days: 325,595 vs down days: 116,442. Ratio: 2.8x
TESTING SUPPORT! Stock is at key support level.
Fundamental & Technical Analysis
75Overall
78Fundamental
73Technical
Fundamental Breakdown
Growth Quality
28/30
Revenue CAGR: 19.1% (VERY GOOD, 13/15). Profit CAGR: 22.7% (EXCELLENT, 15/15).
Profit Margin
6/10
GOOD EFFICIENCY! 15.8% profit margin - above average profitability.
PEG Valuation
7/10
OVERVALUED! PEG of 2.42 means expensive relative to growth rate.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0.2% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
14/20
MODERATE PUBLIC HOLDING! 26.82% public ownership - balanced ownership structure.
Stability Index
10/10
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
Technical Breakdown
Moving Averages
12/10
BULLISH TREND! 50-day average (1725.3) is above 200-day average (1561.8) - positive signal.
Price Position
2/10
RECOVERY MODE! Current price (1705.3) above 200-day but below 50-day.
Trend Pattern
16/20
TESTING SUPPORT! Stock is at key support level.
52W Performance
2/10
WEAK YEAR! Stock declined 11.8% in the last year.
Volume Sentiment
30/30
BULLISH SENTIMENT! In last 30 days: 12 up days, 17 down days. Avg volume on up days: 325,595 vs down days: 116,442. Ratio: 2.8x
RSI
3/5
NEUTRAL! RSI at 46.7 - balanced momentum.
52W Range
3/5
MID RANGE! Trading at 57.4% of 52W range - neutral zone.
Momentum
2/5
WEAK MOMENTUM! Limited price growth - -1.9% (1 week), -1.6% (1 month), 3.4% (3 months).
Beta
3/5
MARKET ALIGNED! Beta of 1.00 - moves with the market.
POLYMED
Concall / Investor Presentation
Earnings call transcripts & AI summaries
| Quarter | Concall | Summary |
|---|---|---|
| Q1FY272026-08-14 | Concall PDF | |
| Q4FY262026-05-29 | Concall PDF | |
| Q3FY262026-02-11 | Concall PDF | |
| Q2FY262025-11-14 | Concall PDF | |
| Q1FY262025-10-01 | Concall PDF |
Peer Comparison
Healthcare · Medical Instruments & Supplies · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| POLYMED | ₹1,705.30 | 54.9 | 15.8% | 19.1% | 22.7% | -11.8% | 75 | BOUNCE FROM SUPPORT | -7.6% | +32.3% | +30.3% | -1.7% |
| AGARWALEYE | ₹489.80 | 105.3 | 6.7% | 26.9% | 12.3% | +9.9% | 79 | BREAKDOWN | +50.7% | +13.9% | +26.0% | +8.8% |
| TARSONS | ₹341.30 | 164.1 | 2.5% | 14.3% | -43.8% | -0.8% | 62 | CONSOLIDATING UP | -177.8% | -133.3% | +20.6% | -8.9% |
| LAXMIDENTL | ₹195.00 | 34.8 | 10.8% | 19.5% | – | -41.3% | 55 | CONSOLIDATING DOWN | +22.6% | +2.0% | +13.5% | +1.1% |
| LENSKART | ₹683.20 | 178.9 | 6.8% | 35.4% | 67.0% | +75.4% | 72 | APPROACHING RESISTANCE | +269.1% | +10.7% | +43.3% | +7.9% |
| ALIVUS | ₹1,401.80 | 28.6 | 23.3% | 6.9% | 6.5% | +42.7% | 77 | APPROACHING SUPPORT | +31.8% | -1.6% | +6.4% | -7.1% |
| COHANCE | ₹459.00 | 166.3 | 5.0% | 18.3% | -24.2% | -51.4% | 62 | APPROACHING RESISTANCE | -149.3% | -223.0% | -23.1% | -31.8% |
| APLLTD | ₹847.40 | 24 | 8.9% | 9.5% | 25.4% | -11.0% | 84 | BREAKOUT | +12.1% | -14.6% | +25.7% | +16.4% |
Data from TradeAlone · Updated daily
POLYMED News
